[1]Shabayek S, Spellerberg B. Group B streptococcal colonization, molecular characteristics, and epidemiology[J]. Front Microbiol, 2018, 9(437):1-14.
[2]Khatami A, Randis T M, Tavares L, et al. Vaginal co-colonization with multiple group B streptococcus serotypes[J]. Vaccine. 2019, 37(3):409-411.
[3]Bobadilla F J, Novosak M G, Cortese I J, et al. Prevalence, serotypes and virulence genes of Streptococcus agalactiae isolated from pregnant women with 35-37 weeks of gestation[J]. BMC Infect Dis, 2021, 21(1):73.
[4]赵晶,刘静娴,刘瑛.无乳链球菌分子流行病学研究进展[J].中国感染与化疗杂志, 2021, 21(4):489-494.
[5]Verani J R,Mcgee L,Schrag S J. Prevention of perinatal group B streptococcal disease-revised guidelines from CDC,2010[J]. MMWR Recomm Rep, 2010, 59(RR-10):1-36.
[6]孙振球.医学统计学[M].北京:人民卫生出版社,2002:112-113.
[7]Ali M M, Woldeamanuel Y, Woldetsadik D A, et al. Prevalence of group B streptococcus among pregnant women and newborns at Hawassa University comprehensive specialized hospital, Hawassa, Ethiopia[J]. BMC Infect Dis, 2019,19(1):325.
[8]王莹, 何佩, 陈莉, 等.孕晚期生殖道B族链球菌感染的影响因素分析[J].中华医院感染学杂志,2019,29(17):2700-2704.
[9]Safari D, Gultom S M, Tafroji W, et al. Prevalence, serotype and antibiotic susceptibility of group B streptococcus isolated from pregnant women in Jakarta, Indonesia[J]. PLoS One. 2021,16(5):e0252328.
[10]Furfaro L L, Nathan E A, Chang B J, et al. Group B streptococcus prevalence, serotype distribution and colonization dynamics in Western Australian pregnant women[J]. J Med Microbiol, 2019,68(5):728-740.
[11]郑美玲,李俊,邱辉,等.妊娠合并B族链球菌感染相关因素调查[J].中国病原生物学杂志,2022,17(6):682-684,688.
[12]解安霞,李惠琴,刘占梅.452例妊娠晚期孕妇B族链球菌感染及妊娠结局调查和定植高危因素分析[J].中国病原生物学杂志,2020,15(8):967-970.
[13]陈华, 俞萍, 张吉平, 等. 围生期妇女生殖道感染B族链球菌耐药基因及毒力基因分析[J]. 中华医院感染学杂志, 2021, 31(12):1916-1920.
[14]李东, 张树琛, 时琰丽, 等. 北京地区孕晚期妇女定植B族链球菌耐药状况与血清型分布情况分析[J]. 首都医科大学学报,2018,39(4):591-595.
[15]林雅茵,林新祝,郑欣怡,等.B族链球菌血清型和基因型及耐药性的研究[J].中华医院感染学杂志, 2020, 30(9):1292-1296.
[16]Russell N J, Seale A C, ODriscoll M, et al. Maternal colonization with group B streptococcus and serotype distribution worldwide: systematic review and meta-analyses[J]. Clin Infect Dis, 2017,65(Suppl 2):S100-S111.
[17]殷晓辰, 林雅华.B族链球菌疫苗研究现状及展望[J].中国生物制品学杂志,2018, 31(11):1274-1278,1282。
[18]Baker C J, Rench M A, McInnes P. Immunization of pregnant women with group B streptococcal type III capsular polysaccharide-tetanus toxoid conjugate vaccine[J]. Vaccine, 2003,21(24):3468-3472.
[19]郭丹, 曹雪莲, 温国明, 等.深圳孕妇定植B族链球菌的分子分型研究[J].广东医学, 2017, 38(22):3463-3465.
[20]Lee H T, Kim S Y, Park P W, et al. Detection and genomic analysis of genital group B streptococcus in pregnant Korean women[J]. J Obstet Gynaecol Res, 2019,45(1):69-77.
[21]Teatero S, Ferrieri P, Martin I, et al. Serotype distribution, population structure, and antimicrobial resistance of group B streptococcus strains recovered from colonized pregnant women[J]. J Clin Microbiol, 2017, 55(2):412-422.
[22]Gao K K, Gao C Y, Huang L F,et al. Predominance of III/ST19 and Ib/ST10 lineages with high multidrug resistance in fluoroquinolone-resistant group B streptococc isolates in which a new integrative and conjugative element was identified[J]. Front Microbiol, 2021,11:609526.
[23]中华医学会围产医学分会,中华医学会妇产科学分会产科学组.预防围产期B族链球菌病(中国)专家共识[J].中华围产医学杂志,2021,24(8):561-566.
[24]高坎坎,钟华敏,梁绮华,等. B族链球菌相关疫苗的研究进展[J].中华妇幼临床医学杂志(电子版),2017,13(1):116-119.
|